Latest / PETRI DISH PERSPECTIVES
Episode 18: Gilead
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health with a cure for hepatitis C, and pushed into oncology with cutting-edge CAR-T therapies.
But alongside these triumphs came firestorms of criticism, from the $84,000 price tag of Sovaldi to debates…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.